Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2021		$ 136,968	$ (67,450)	$ 69,518
Balance (in Shares) at Dec. 31, 2021	3,785,383
Issuance of common stock upon exercise of stock options		27		27
Issuance of common stock upon exercise of stock options (in Shares)	3,727
Issuance of common stock upon exercise of common stock warrants
Issuance of common stock upon exercise of common stock warrants (in Shares)	2
Issuance of common stock pursuant to Employee Stock Purchase Plan		28		28
Issuance of common stock pursuant to Employee Stock Purchase Plan (in Shares)	5,942
Settlement of restricted stock units
Settlement of restricted stock units (in Shares)	9,373
Vesting of founders’ restricted stock		10		10
Stock-based compensation expense		4,091		4,091
Net loss			(37,685)	(37,685)
Balance at Dec. 31, 2022		141,124	(105,135)	35,989
Balance (in Shares) at Dec. 31, 2022	3,804,427
Issuance of common stock upon exercise of stock options		388		388
Issuance of common stock upon exercise of stock options (in Shares)	54,580
Issuance of common stock through underwritten offering, net of discounts and commissions and issuance costs of $6.6 million	$ 1	96,969		96,970
Issuance of common stock through underwritten offering, net of discounts and commissions and issuance costs of $6.6 million (in Shares)	6,900,000
Issuance of common stock through ATM offering, net of commissions and offering costs of $0.1 million		4,509		4,509
Issuance of common stock through ATM offering, net of commissions and offering costs of $0.1 million (in Shares)	233,747
Reclassification of common stock warrants from liability to equity		725		725
Shares withheld for taxes		(960)		(960)
Shares withheld for taxes (in Shares)	(80,462)
Issuance of common stock pursuant to Employee Stock Purchase Plan		64		64
Issuance of common stock pursuant to Employee Stock Purchase Plan (in Shares)	12,999
Settlement of restricted stock units
Settlement of restricted stock units (in Shares)	238,605
Vesting of founders’ restricted stock		9		9
Stock-based compensation expense		5,211		5,211
Net loss			(64,465)	(64,465)
Balance at Dec. 31, 2023	$ 1	$ 248,039	$ (169,600)	$ 78,440
Balance (in Shares) at Dec. 31, 2023	11,163,896